Physician profile
Michael Maier
NPI 1750317954
$8,187.38
in general payments reported to CMS, 2019-2025
11 companies · $3,637 in 2025
The $3,637 reported for 2025 was more than what 79% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,514 · 2022: $1,236 · 2023: $116 · 2024: $1,684 · 2025: $3,637.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,900 · Food and Beverage: $1,512 · Entertainment: $24.94.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,900.19 |
| Food and Beverage | $1,512.27 |
| Entertainment | $24.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medinc of Texas | $3,374.76 | 2019-2025 | |
| Arthrex, INC. | $2,864.42 | 2024-2025 | |
| Encore Medical, Lp | $1,286.65 | 2024 | Djo Surgical |
| Smith+Nephew, INC. | $408.24 | 2019-2023 | Real Intelligence, Journey II |
| Wound Management Technologies, INC | $66.27 | 2019 | |
| Vericel Corporation | $66.23 | 2025 | Maci |
| Stryker Corporation | $34.29 | 2025 | Mako, Blueprint Patient Specific Instrumentation |
| Orthalign INC | $32.86 | 2023 | Orthalign Plus |
| Globus Medical, INC. | $22.31 | 2024 | Precice Intramedullary Limb Lengthening System |
| Depuy Synthes Sales INC. | $17.87 | 2025 | Orthovisc, Monovisc |
| Paragon 28, INC. | $13.48 | 2023 | Activcore Nail |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Maier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.